FDA centennial ceremony
This article was originally published in The Tan Sheet
Executive SummaryFDA celebrated its centennial June 30 with a ceremony held at the agency's Harvey W. Wiley building in College Park, Md. U.S. Health & Human Services Secretary Michael Leavitt and Acting FDA Commissioner Andrew von Eschenbach, MD, delivered presentations during the event. Additionally, FDA Deputy Commissioners and other top officials provided "an overview of the coming public health opportunities and challenges." Murray Lumpkin, MD, Deputy Commissioner, International Programs & Special Programs addressed "International Perspectives" and "Medical & Scientific Perspectives" were addressed by Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb, MD. The ceremony closed with a rendition of the "FDA Centennial Anthem" by the FDA Chorus and the U.S. Public Health Service Wind Ensemble...
You may also be interested in...
Most of the foreign OTC drug firms targeted in latest warnings FDA published, including the GUM oral care brand manufacturer, were placed on import alert due to GMP violations. Each was inspected by FDA during June, July or May 2019, when the agency was wrapping up an initiative to inspect all previously uninspected drug manufacturers.
AstraZeneca will reacquire Allergan's investigational IL-23 inhibitor brazikumab, and Nestle is to buy its GI drug Zenpep, which had nine-month revenue of $208m.
The US agency is engaged with an ethylene oxide (EtO) sterilizer in Illinois that has temporarily closed to determine if there are any potential risks to the medical device supply chain. While the plant shut down about a month ago, regulators have only recently been made aware of the decision, which resulted from a law passed last year by the state legislature.